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AbstrACt
Objective A systematic review and meta-analysis to 
estimate the magnitude of the association between 
alcohol consumption and the risk of community-acquired 
pneumonia (CAP) in adults was undertaken.
Design Systematic review and meta-analysis.
Methods Comprehensive searches of Medline, 
Embase and Web of Science were carried out to identify 
comparative studies of the association between alcohol 
intake and CAP between 1985 and 2017. Reference lists 
were also screened. A random-effects meta-analysis was 
used to estimate pooled effect sizes. A dose–response 
meta-analysis was also performed.
results We found 17 papers eligible for inclusion in 
the review, of which 14 provided results which could be 
pooled. Meta-analysis of these 14 studies identified an 
83% increased risk of CAP among people who consumed 
alcohol or in higher amounts, relative to those who 
consumed no or lower amounts of alcohol, respectively 
(relative risk=1.83, 95% CI 1.30 to 2.57). There was 
substantial between-study heterogeneity, which was 
attributable in part to differences in study continent, 
adjustment for confounders and pneumonia diagnosis 
(clinical vs death). Dose–response analysis found that for 
every 10–20 g higher alcohol intake per day, there was an 
8% increase in the risk of CAP.
Conclusions The findings suggest that alcohol 
consumption increases the risk of CAP. Therefore, 
strengthening policies to reduce alcohol intake would be 
likely to reduce the incidence of CAP.
IntrODuCtIOn 
Pneumonia is a major cause of global 
morbidity and mortality. In 2014 in the 
USA, pneumonia (including influenza) 
was the eighth leading cause of death,1 and 
according to the WHO, in 2015 pneumonia 
was responsible for 16% of all deaths in chil-
dren aged under 5 years.2 Community-ac-
quired infections are the most common cause 
of pneumonia, and with an annual incidence 
in Europe and North America of between 5 
and 11 cases per thousand adults,3 commu-
nity-acquired pneumonias (CAPs) account 
for a total of 4 million deaths annually.4 
Globally, Streptococcus pneumoniae is the most 
common pathogen causing CAP.5 The annual 
incidence of CAP requiring hospitalisation 
among US adults is 24.8 cases per 10 000 
adults, with the highest incidence especially 
in oldest people.6 Patients with severe CAP 
admitted to European intensive care units 
have a mortality rate of 27% at 6 months.7 
Pneumonia is more common with 
increasing age,8 9 among people who 
smoke,10–12 have low body mass index,13 or 
have comorbidities including other respira-
tory diseases,12 14 cardiovascular diseases,14 
stroke,14 dementia,11 14 and liver or renal 
disease.14 Alcohol consumption is a potential 
risk factor for pneumonia. There are several 
possible mechanisms to explain the obser-
vation that alcohol consumption increases 
the risk of pneumonia, including the seda-
tive properties of alcohol which can reduce 
oropharyngeal tone, leading to an increased 
risk of aspiration of microbes. Furthermore, 
high levels of alcohol intake can modify 
alveolar macrophage function, hence 
diminishing pulmonary defence against 
infection.15 16 Also, high alcohol consump-
tion is often associated with malnutrition17 
as it interacts with nutrient metabolism and 
utilisation,18 resulting in the impairment of 
immunity and increased CAP risk.
To date, however, evidence on the associa-
tion between alcohol consumption and CAP is 
limited. A systematic review and meta-analysis 
published in 2010, using evidence published 
before August 2009, found a 6% increase in 
strengths and limitations of this study
 ► This study represents a comprehensive review of 
the global literature with no language restrictions, 
while adhering to the guidelines of the Preferred 
Reporting Items for Systematic Reviews and Meta-
Analyses and the Meta-analysis Of Observational 
Studies in Epidemiology.
 ► Heterogeneity was explored using subgroup analy-
sis based on a priori defined factors.
 ► A dose–response analysis of alcohol consumption 
was also performed.
 ► Confounding as a result of the existence of other 
factors that were not usually adjusted for in the in-
cluded studies (eg, socioeconomic status, malnutri-
tion) could not be explored.
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the risk of pneumonia per standard drink of 12 g of pure 
alcohol per day, but the number of studies reviewed (five) 
was small.19 However, there is an increase in the interest 
on this topic, and also several studies have been published 
in the past 9 years. For this reason we have carried out a 
systematic review and meta-analysis to quantify the associ-
ation between alcohol consumption and the risk of CAP.
MethODs
The systematic review and meta-analysis was carried out in 
adherence to the guidelines of the Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses20 and 
the Meta-analysis Of Observational Studies in Epide-
miology21. The protocol was published in the National 
Institute for Health Research international prospective 
register of systematic reviews (PROSPERO) under PROS-
PERO registration number 42015029910.
Patient and public involvement
No patients or the public were involved in this review.
Inclusion criteria
The Population-Exposure-Outcome-Study Design (PICO) 
criteria were used to determine eligibility of the articles 
based on the type of study design, type of population, 
type of exposure and outcome. We included all compara-
tive study designs (longitudinal, cohort, case–control and 
cross sectional) assessing the association between alcohol 
intake and the risk of CAP in generally representative 
adult populations (≥18 years), and therefore excluded 
studies of selected populations such as people with HIV, 
hepatitis B or C virus infection, and those with hospi-
tal-acquired pneumonia. Where possible, we also anal-
ysed the association between alcohol consumption and 
the occurrence of pneumonia due to specific organisms 
(eg, S. pneumoniae).
exposure ascertainment
Alcohol consumption was defined either by self-report 
(interview or questionnaire) or using medical records. 
Also, alcohol use corresponded to drinking levels (low, 
moderate, heavy and alcoholism) or to frequency 
measures (grams/units/drinks per day/week).
Outcome ascertainment
CAP diagnosis was based on clinical diagnosis (chest X-ray, 
blood test), physician diagnosis and medical records 
including the International Classification of Diseases 
(ICD) codes, or self-report.
search strategy
Comprehensive search strategies were applied to 
Medline (via Ovid), Embase (via Ovid) and Web of 
Science databases for the period from December 1985 to 
December 2017. We used search filters for observational 
study designs22 and search terms for both outcome and 
exposure developed from relevant Cochrane Review 
groups.23 When searching, medical subject heading 
terms were used for Medline and Embase, whereas free-
text words were used for Web of Science. The Medline 
search filters were the following: [exp Alcohol-Related 
Disorders/OR Alcohol Drinking/OR (alcohol adj3 
(drink$ ORor intoxicat$ OR use$ OR abus$ OR misus$ 
OR risk$ OR consum$ OR withdraw$ OR detox$ OR 
treat$ OR therap$ OR excess$ OR reduc$ OR cessation 
OR intervention$)).tw. OR (drink$ adj3 (excess OR 
heavy OR heavily OR harm OR harmful OR hazard$ 
OR binge OR problem$)).tw. OR alcoholic$.tw.] AND 
[exp Respiratory Tract Infections/OR (acute respiratory 
infection*.tw.) OR (lower respiratory infection*.tw.) OR 
(lower respiratory tract infection*.tw.) OR exp Pneu-
monia/OR (pneumon* OR bronchopneumon* OR 
pleuropneumon*).tw. OR exp Bronchitis/OR (bron-
chit* OR bronchiolit*).tw]. The full search strategy 
is presented in online supplementary table E1). The 
reference lists of included studies were also screened 
in order to identify further potentially eligible studies. 
No language limitation was imposed, and where neces-
sary papers were translated into English. Where there 
was more than one report of findings from the same 
population (eg, an abstract and then a full paper), the 
most recently published version of the study was used. 
Screening of titles and abstracts, as well as the full text, 
was conducted independently by two reviewers (ES and 
JL-B). Any disagreements were resolved through discus-
sion or with the help of a third reviewer (JB).
Data extraction
Two reviewers (ES and JL-B) independently extracted 
data using a previously piloted form (see online supple-
mentary table E2), which included the following informa-
tion: author, year, study design, definitions of exposure 
(alcohol) and outcome (CAP), geographical location, 
reference population, and adjustment for confounders.
For categorical measures of alcohol drinking, where 
possible we compared any alcohol consumption with no 
alcohol consumption (reference group), or else used the 
lowest exposed category as the reference group. Also, 
in the main analysis, categorical measures of alcohol 
consumption were further defined as levels of consump-
tion: light, moderate, heavy, binge and alcoholism. 
Grams of daily alcohol consumption were used as a stan-
dard measure, defining one drink as 0.6 ounces, 14.0 g 
or 1.2 tablespoons of pure alcohol.24 Where possible, we 
followed the Centers for Disease Control and Preven-
tion guidelines for the definition of heavy drinking as a 
weekly consumption of 15 or more drinks for men, and 8 
or more drinks for women; binge drinking as 5 or more 
drinks during a single occasion for men, or 4 or more 
for women; and excessive drinking as the presence of 
either binge or heavy drinking.24 The Dietary Guidelines 
for Americans define moderate alcohol drinking as the 
daily consumption of up to one drink for women and two 
drinks for men.25 Otherwise we accepted the definitions 
of alcohol that the included studies used.
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Quality assessment
Two authors (ES and JL-B) independently assessed the 
methodological quality of the included studies using the 
Newcastle-Ottawa Scale.26 In the process of quality assess-
ment of each article, a maximum score of 9 stars can 
be obtained, whereas studies with lower quality obtain 
fewer stars. In case of a cohort study, the cohort study 
criteria were used, whereas for case–control studies the 
case–control criteria were used. However, for a cross-sec-
tional study, a modified version of the case–control 
study criteria was used and in this case a maximum of 7 
stars was given. All studies, irrespective of their design, 
were considered to be of high quality if they obtained a 
score of ≥6 stars. Discrepancies were resolved through 
discussion and consensus. We did not attempt to assess 
the methodological quality for studies published only in 
abstract form.
statistical analysis
Relative measures of risk were extracted as ORs, relative 
risks (RR) or HRs with 95% CIs. Where available, we used 
measures of risk adjusted for smoking and socioeconomic 
status and extracted the results separately for men and 
women. Where raw data were extracted from studies, 
we estimated ORs for case–control studies and RRs for 
longitudinal, cohort and cross-sectional studies. Where 
exposure to alcohol was reported using quantiles, or cate-
gories, we extracted adjusted effect measures relating to 
a comparison of the highest with the lowest exposure 
group.
The pooled RR and the 95% CI were estimated through 
pooling ORs and RRs together, since it was assumed 
that these two measures of effect would be similar due 
to the outcome measure being uncommon (prevalence 
<~10%).27 However, HRs were not pooled with other 
effect measures. The decision to present only relative 
risks was made due to issues associated with using absolute 
risks, namely the risk difference is naturally constrained 
which may create difficulties when applying results to 
other patient groups and settings. Therefore, absolute 
measures are less likely to be generalisable.28 Meta-anal-
ysis was conducted, based on the DerSimonian and 
Laird’s random-effects model, to pool the results from 
the individual studies.
Heterogeneity between studies was quantified using 
I2 statistics,29 and explored using subgroup analyses 
according to study quality, study design, adjustment for 
confounders, alcohol reference group (no alcohol vs 
lowest exposed category), CAP diagnosis (clinical diag-
nosis vs death records), geographical location (low-in-
come and middle-income countries vs high-income 
countries) and measure of effect estimated (ORs vs RRs). 
Funnel plots were used as a visual aid to detect publica-
tion bias, and where data for at least 10 studies were avail-
able we formally assessed publication bias using Egger’s 
asymmetry test. We performed all analyses using Stata 
V.14 and Review Manager V.5.3. All p values <0.05 were 
deemed to represent statistical significance.
Dose–response assessment
To assess the evidence for causality, we applied a modified 
version of Hill’s criteria to assess causation30 on strength of 
association, consistency, temporality, biological gradient 
and plausibility. To assess the biological gradient criterion, 
we performed a random-effects dose–response meta-anal-
ysis,31 32 where we assumed a linear dose–response rela-
tion and allowed for study-level correlations across the 
categories of quantities of alcohol. The dose–response 
relation between alcohol consumption and CAP was anal-
ysed using the subgroup of studies including at least three 
different categories of exposure, standardised for anal-
ysis to grams per day, and where appropriate using the 
midpoint of categories defined by ranges of intake. If the 
highest exposure category was open-ended, we took the 
highest category midpoint to be the lower bound plus 1.2 
times the lower boundary.33 When available we included 
results for men and women separately.
Separate dose–response meta-analyses were conducted 
for cohort/longitudinal and case–control/cross-sectional 
studies. Dose categories relating to quantities of alcohol 
were created to equate to 10–20 g of pure alcohol per 
day (approximately one drink per day); where studies 
reported categories which contained the same dose 
ranges, we collapsed these into a single dose category 
through estimating a pooled effect estimates based on a 
fixed-effect meta-analysis model. Where necessary, effect 
estimates and 95% CI were back-calculated from floated 
to conventional CIs to enable comparisons to be made 
with the reference group (non-drinkers or the lowest 
exposed category).34
results
The searches identified a total of 4589 studies published 
between December 1985 and December 2017, of which 
17 were eligible for inclusion in the systematic review 
(figure 1). The characteristics of the 17 included 
studies are presented in table 1. A total population 
of 287 184 people were included in our review. Seven 
studies used a cohort or longitudinal design,10 35–40 
nine used a case–control design11 41–48 and one used a 
cross-sectional design.49 Eight studies were conducted 
in America,10 11 39 40 46–49 five in Europe,37 41 43–45 two in 
Asia35 36 and two in Australia.38 42 Three studies reported 
separate estimates of the association between alcohol and 
CAP for men and women,10 41 44 and 12 studies reported 
effect estimates adjusted for confounders.10 35 36 39 41 43–49
The majority of studies assessed alcohol consumption by 
self-report, based either on a standardised questionnaire 
or on an interview, while five studies used reported intake 
data from medical records.11 37 40 46 47 The reference group 
for nine studies comprised people who never consumed 
alcohol,10 35 36 38 42 44 45 47 48 whereas the reference group 
for the remaining eight studies comprised people who 
consumed the lowest quantity of alcohol.11 37 39–41 43 46 49
Seven studies ascertained CAP using a clin-
ical diagnosis, and five of these used chest X-ray 
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radiography.42–45 48 A further seven studies ascertained 
CAP using ICD codes35 36 38 40 41 46 and medical records,46 
and two studies used self-report interviews.39 49 The 
remaining study ascertained CAP via physician diagnosis 
using medical records.10
The methodological quality of the case–control, cohort 
and cross-sectional studies ranged from 5 to 8, with a 
median score of 6. Ten studies were deemed to be of high 
quality (>6 score),10 35 37–39 41 43 45–47 whereas lower scores 
tended to arise from failure to adjust for confounders 
or using self-reported methods to ascertain alcohol 
consumption. The results of the quality assessment are 
presented in detail in table 2.
Meta-analysis findings
Fourteen of the 17 included studies provided data from 
which pooled RRs could be estimated, and a pooled 
analysis of these studies found the risk of CAP to be signifi-
cantly increased in people who consumed alcohol at all 
or in higher amounts, relative to those who consumed 
no or lower amounts of alcohol, respectively (pooled 
RR=1.83, 95% CI 1.30 to 2.57, I2=91%; figure 2). There 
was no evidence of publication bias detected visually via 
a funnel plot (see online supplementary figure E1) and 
statistically via Egger’s asymmetry test (p=0.596).
Subgroup analyses exploring the reason for heteroge-
neity in the meta-analysis of these 14 studies are presented 
in online supplementary table E3). Heterogeneity was 
not explained by study design (case–control, longitu-
dinal/cohort, cross-sectional; p for subgroup differ-
ences=0.07), methodological quality (high vs low; p=0.09) 
or gender (male vs female; p=0.74). However, significant 
differences were found according to adjustment for 
Figure 1 Study selection.
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confounders (adjusted vs unadjusted; p=0.03), conti-
nent of study (America, Europe, Australia; p=0.0003), 
and ascertainment of CAP (clinical diagnosis vs death 
records; p=0.002). Furthermore no difference was found 
for studies that presented OR estimates compared with 
studies that presented RR estimates (p for subgroup 
differences=1.00).
Additionally, no significant differences were found by 
the definition of the reference group for alcohol consump-
tion (p=0.39; figure 2). However, high heterogeneity 
(I2=95%) was detected within the second subgrouping 
which used the lowest category of exposure as the refer-
ence group, where the following definitions were used: no 
alcoholism,37 46 no alcohol abuse,40 moderate drinking,11 
≤30 drinks/month,49 ≤0.5 bottles of vodka,41 <100 g/day 
for men and <80 g/day for women,43 and <20 g/day and 
<10 g/day for men and women, respectively39; however, 
the gradient of exposure did not seem to be related to the 
magnitude of effect.
A sensitivity analysis restricted to the six studies which 
provided smoking-adjusted estimates found a larger 
magnitude of effect compared with the main analysis 
(pooled RR=2.01, 95% CI 1.25 to 3.23, I2=93%, 6 studies). 
Similarly the studies that provided age-adjusted effect 
estimates found a risk of 1.90 (pooled RR=1.90, 95% CI 
1.20 to 3.02, I2=93%, 7 studies).
The remaining three studies presented effect estimates 
as HRs,35 36 38 and a pooled analysis of these studies esti-
mated an HR for CAP in relation to alcohol consumption 
of 0.90 (pooled HR=0.90, 95% CI 0.79 to 1.03, I2=0, 3 
studies).
Two studies assessing the effect of alcohol on pneumo-
coccal disease-specific strains of pneumonia were iden-
tified.11 47 A pooled analysis of these studies found that 
there was more than a doubling of risk of S. pneumoniae 
CAP in people who consumed alcohol (RR=2.16, 95% CI 
1.05 to 4.48, I2=42%).
biological gradient meta-analysis
Five of the included studies provided data enabling a 
dose–response meta-analysis,10 41 42 44 45 of which one used 
a cohort design (data reported separately for men and 
women) and four were case–control studies. A pooled 
analysis of the dose–response data from the cohort study 
found no significant gradient in the quantity of alcohol 
associated with the risk of CAP (p for trend=0.136). In 
contrast, the pooled analysis of the dose–response data 
from the four case–control studies indicated that there 
was a significant gradient in the quantity of alcohol asso-
ciated with an 8% increase in the risk of CAP for every 
10–20 g of pure alcohol consumed per day (equivalent 
to 1 drink/day) (pooled RR=1.08, 95% CI 1.06 to 1.09, 
p<0.0001; figure 3).
DIsCussIOn
Alcohol consumption is a recognised and avoidable risk 
factor for a range of diseases and injuries, including 
Table 2 Quality assessment: Newcastle-Ottawa Scale 
Study, year
Number of stars
Selection* Comparability† Exposure‡ Overall
Almirall et al,45 1999 4 1 1 6/9
Almirall et al,44 2008 3 1 1 5/9
Baik et al,10 2000 4 2 2 8/9
Breitling et al,39 2016 3 2 2 5/9
Clough et al,42 2003 4 0 1 5/9
Fernández-Solá et al,43 1995 3 2 1 6/9
Inoue et al,36 2007 3 1 1 5/9
Jackson et al,46 2009 4 1 1 6/9
Koivula et al,37 1994 4 1 3 8/9
Lipsky et al,111986 3 0 2 5/9
Loeb et al,48 2009 2 2 1 5/9
Phung and Wang,38 2013 3 0 3 6/9
Quraishi et al,49 2013 1 0 1 2/6
Shen et al,35 2013 3 2 3 8/9
Watt et al,47 2007 4 2 1 7/9
Yende et al,40 2013 4 0 2 6/9
Zaridze et al,41 2009 3 2 1 6/9
*Maximum 4 stars.
†Maximum 2 stars.
‡Maximum 3 stars.
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neuropsychiatric conditions, gastrointestinal and cardio-
vascular diseases, cancer, suicide, violence and tubercu-
losis.50 To date, however, the association between alcohol 
consumption and pneumonia risk has attracted relatively 
little attention.
summary of the findings
This meta-analysis of studies published over the past 30 
years demonstrates a clear and statistically significant 
relation between alcohol consumption and the risk of 
CAP. The effect was strong, with a 1.8-fold increase in risk 
among those who consumed alcohol at all or in higher 
amounts, relative to those who consumed no or lower 
amounts of alcohol, respectively, and significantly related 
to the level of intake, with no evidence of publication bias. 
The dose–response analysis indicated that consuming 
drinks that contain 10–20 g of alcohol per day was linked 
to an 8% increased risk of acquiring CAP. Furthermore, 
the findings of the subgroup analysis indicated significant 
differences in the risk of pneumonia according to conti-
nent of the study, with Europe having the highest rate 
(threefold) for CAP risk.
strengths and limitations
This study represents a comprehensive review of the 
global literature with no language restriction, making this 
analysis the most complete to date and our findings likely 
to be generalisable. There was significant heterogeneity 
between the studies in our analysis, but our subgroup 
analyses indicate that this arose primarily from the conti-
nent in which the study was carried out (America, Europe, 
Australia), adjustment for confounders and the ascertain-
ment of CAP (death vs clinical diagnosis). Misclassifica-
tion bias arising from inclusion of non-drinkers in the 
lowest category of alcohol intake in some studies can be 
Figure 2 Forest plot of alcohol consumption and risk of community-acquired pneumonia (CAP): subgroup analysis based on 
reference group (never drinking vs lowest drinking category).
Figure 3 Linear dose–response meta-analysis for the 
association between alcohol intake categories (g/day) and 
the risk of community-acquired pneumonia.
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another possible limitation in our review, but will result in 
a more conservative estimate of effect. A dose–response 
relationship was identified. However the included studies 
did not report dose–response relations separately for men 
and women, so we are unable to carry out a comparative 
analysis. Furthermore, confounding as a result of the exis-
tence of other factors that were not usually adjusted for in 
the included studies (eg, socioeconomic status, malnutri-
tion) could not be explored.
Comparison with other studies
Our findings extend those of an earlier review and 
meta-analysis carried out in 2010.19 Another review 
focused on the risk factors for invasive pneumococcal 
diseases indicated an elevated risk for invasive pneumo-
coccal disease due to alcohol consumption in six of the 
four studies included in the meta-analysis model.51 Like-
wise, another recent meta-analysis indicated an elevated 
risk for invasive pneumococcal disease due to alcohol 
consumption in six of the four studies included in the 
meta-analysis model.52 Similarly our separate meta-anal-
ysis focused on pneumococcal infections including two 
of these studies, due to our eligibility criteria, showed an 
elevated risk for pneumococcal acquisition.
A previous systematic review and meta-analysis found 
that people with a daily alcohol consumption of either 24 
g, 60 g and 120 g have a 12%, 33% and 76% increased risk 
of CAP, respectively.19 Our dose–response analysis gener-
ated a slightly less strong effect, of an 8% increase in risk 
per 10–20 g of (pure) alcohol consumed per day.
A general systematic review published by Almirall et al 
in 201753 focused on the risk factors of CAP, but provided 
only a narrative summary of findings and stating that 
no definite conclusion could be drawn. In contrast, our 
review found evidence of a doubling in the risk of CAP 
in people who consumed alcohol. Furthermore, our 
demonstration of a significant exposure–response associ-
ation increases the likelihood, given the strength of the 
observed association and its consistency across a range of 
subgroups, that the observed association is causal. Further 
evidence of causality arises from studies demonstrating 
that alcohol consumption impairs alveolar macrophages 
and increases carriage of pneumonia pathogens.15 16 54
Clinical implications
The findings from the present review highlight the need to 
address high alcohol consumption as a means to prevent 
CAP. Clinicians managing patients with pneumonia 
could, for example, counsel reducing alcohol intake as a 
means to prevent further episodes, and those addressing 
high alcohol consumption in more general terms could 
add an increased risk of pneumonia as a further reason 
to reduce intake.
Our findings also have implications for public health: 
in Europe, for example, the estimated annual cost of CAP 
is approximately €10.1 billion55 and might be reduced 
substantially by more proactive clinical and public health 
measures to reduce alcohol consumption.
COnClusIOn
Our findings thus provide clear evidence that alcohol 
increases the risk of pneumonia. Informing people who 
drink alcohol of this risk, especially those who consume 
high levels of alcohol, both in clinical contacts and 
through public health policy, may therefore help to 
prevent this disease.
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